DelveInsight’s ‘Transcatheter Aortic Valve Replacement/Implantation- Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Transcatheter Aortic Valve Replacement/Implantation, historical and forecasted market trends in trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
The Transcatheter Aortic Valve Replacement/Implantation market report provides an overview of Transcatheter Aortic Valve Replacement/Implantation, applications of Transcatheter Aortic Valve Replacement Implantation, as well as its advantages and limitations. Additionally, the report provides insights on the market share of the individual TAVR devices, current and forecasted TAVR implants market size from 2018 to 2026, segmented by seven major markets. The report also covers the market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Transcatheter Aortic Valve Replacement (TAVR), also known as Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive surgery performed to insert a new valve without removing the damaged one. The narrowed aortic valve, which has failed to open properly (aortic valve stenosis), is replaced by a new one. Generally, a valve replacement requires an open-heart surgery with a sternotomy, where the chest is surgically opened for the procedure but the TAVR is done through very small openings that leave all the chest bones in place. Aortic valve stenosis is because the heart's aortic valve has thickened and calcified, preventing the valve from opening fully and limiting the blood flow from the heart to the rest of the body. This can lead to heart failure and sudden cardiac deaths.
There are three approaches available for a cardiologist or surgeon to choose, first the transfemoral approach, second the transapical approach, and Transaortic implantation. The transfemoral approach does not require a surgical incision in the chest and is performed through the femoral artery (large artery in the groin), whereas the transapical approach requires a minimally invasive surgery with a small incision in the chest and entering through a large artery in the chest or through the tip of the left ventricle (the apex). Transaortic Implantation is an alternative to the transfemoral and transapical approaches.
This procedure is suggested for people who have symptomatic severe aortic stenosis at low, intermediate, or high risk for standard valve replacement surgery. It is helpful for patients who have limited options for the repair of their aortic valve. TAVR improves quality of life.
Study Period: 2018–2026
More companies in the report…
This segment of the report provides a brief competitive analysis of Transcatheter Aortic Valve Replacement (TAVR), to help understand the competition in the market. It gives a comparative understanding of the Transcatheter Aortic Valve Replacement based on procedure types.
This segment illustrates the market of transcatheter aortic valve replacement across 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR
By Procedure Type
Transcatheter Aortic Valve Replacement: Market Drivers and Barriers
The report provides insights into the market driving factors and the barriers shaping the Transcatheter Aortic Valve Replacement/Implantation (TAVR) Market.
Factors responsible for driving the TAVR market include the increasing geriatric population, the incidence of cardiovascular diseases, adoption of advanced surgical procedures, and rising investments in health care. However, the market will be hindered by the high cost of TAVR and risks like blood vessel complication, stroke, arrhythmias, infections, and others associated with TAVR procedure.
Developmental Activities
The market of TAVR is witnessing technological advancements with the introduction of new innovative products in the market. There has been rapid growth in the number of hospitals performing TAVR.
According to the data by the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) TVT Registry, TAVR exceeded all forms of surgical aortic valve replacement (SAVR) for the first time in 2019.
To keep up with the market trends, we take KOLs and SME’s opinion working in the Transcatheter Aortic Valve Replacement/Implantation domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns for TAVR market trends. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Scope of the Report
Report Highlights
Market Insights:
Competitive Landscape:
1. Key Insights
2. Executive Summary of Transcatheter Aortic Valve Replacement (TAVR)
3. Transcatheter Aortic Valve Replacement (TAVR): Background and Overview
3.1. Introduction
4. Transcatheter Aortic Valve Replacement (TAVR): Regulatory Scenario
5. Transcatheter Aortic Valve Replacement (TAVR): Reimbursement Scenario
6. Company Profiles
6.1. Medtronic plc
6.1.1. Company Overview
6.1.2. Product Portfolio
6.1.2.1 Product description
6.1.2.2 Regulatory Milestones
6.1.2.3 Research and Development
6.1.2.4 Product Development Activities
6.2. Boston Scientific Corporation
6.2.1. Company Overview
6.2.2 Product Portfolio
6.2.2.1 Product description
6.2.2.2 Regulatory Milestones
6.2.2.3 Research and Development
6.2.2.4 Product Development Activities
6.3. Edwards Lifesciences Corporation
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.2.1 Product description
6.3.2.2 Regulatory Milestones
6.3.2.3 Research and Development
6.3.2.4 Product Development Activities
6.4. Abbott
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.2.1 Product description
6.4.2.2 Regulatory Milestones
6.4.2.3 Research and Development
6.4.2.4 Product Development Activities
6.5 JenaValve Technology, Inc.
6.5.1. Company Overview
6.5.2 Product Portfolio
6.5.2.1 Product description
6.5.2.2 Regulatory Milestones
6.5.2.3 Research and Development
6.5.2.4 Product Development Activities6
6.6 JC Medical, Inc.
6.6.1. Company Overview
6.6.2 Product Portfolio
6.6.2.1 Product description
6.6.2.2 Regulatory Milestones
6.6.2.3 Research and Development
6.6.2.4 Product Development Activities
6.7 St. Jude Medical, Inc.
6.7.1. Company Overview
6.7.2 Product Portfolio
6.7.2.1 Product description
6.7.2.2 Regulatory Milestones
6.7.2.3 Research and Development
6.7.2.4 Product Development Activities
6.8 Bracco SpA
6.8.1. Company Overview
6.8.2 Product Portfolio
6.8.2.1 Product description
6.8.2.2 Regulatory Milestones
6.8.2.3 Research and Development
6.8.2.4 Product Development Activities
6.9 Transcatheter Technologies GmbH
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.2.1 Product description
6.9.2.2 Regulatory Milestones
6.9.2.3. Research and Development
6.9.2.4. Product Development Activities
6.10 NVT AG
6.10.1. Company Overview
6.10.2 Product Portfolio
6.10.2.1 Product description
6.10.2.2 Regulatory Milestones
6.10.2.3 Research and Development
6.10.2.4 Product Development Activities
Products detail in the report…
7. Transcatheter Aortic Valve Replacement (TAVR): Competitive Analysis
8. KOL Views
9. Transcatheter Aortic Valve Replacement devices: Market Analysis in 7MM
9.1. Transcatheter Aortic Valve Replacement: Market Analysis in 7MM by procedure type (2018–2026)
10. Country-Wise Market size of Transcatheter Aortic Valve Replacement in 7MM (2018–2026)
10.1. Market size of Transcatheter Aortic Valve Replacement in the United States
10.1.1. Transcatheter Aortic Valve Replacement: Market Analysis in the United State by procedure type (2018–2026)
10.2. Market size of Transcatheter Aortic Valve Replacement in France
10.2.1. Transcatheter Aortic Valve Replacement: Market Analysis in France by procedure type (2018–2026)
10.3. Market size of Transcatheter Aortic Valve Replacement in Italy
10.3.1. Transcatheter Aortic Valve Replacement: Market Analysis in Italy by procedure type (2018–2026)
10.4. Market size of Transcatheter Aortic Valve Replacement in the UK
10.4.1. Transcatheter Aortic Valve Replacement: Market Analysis in the UK by procedure type (2018–2026)
10.5. Market size of Transcatheter Aortic Valve Replacement in Spain
10.5.1. Transcatheter Aortic Valve Replacement: Market Analysis in Spain by procedure type (2018–2026)
10.6. Market size of Transcatheter Aortic Valve Replacement in Germany
10.6.1. Transcatheter Aortic Valve Replacement: Market Analysis in Germany by procedure type (2018–2026)
10.7. Market size of Transcatheter Aortic Valve Replacement in Japan
10.7.1. Transcatheter Aortic Valve Replacement: Market Analysis in Japan by procedure type (2018–2026)
11. Market Dynamic
11.1. Market Drivers
11.2. Market Barriers
12. PEST Analysis
13. Conclusion and Future Perspective
14. Appendix
14.1. Bibliography
14.2. Report Methodology
15. DelveInsight Capabilities
16. Disclaimer
17. About DelveInsight
List of Tables:
Table 1: Competitive Analysis
Table 2: Transcatheter Aortic Valve Replacement Market Analysis in the 7MM (2018–2026)
Table 3: Transcatheter Aortic Valve Replacement Market Analysis in the 7MM by procedure type (2018–2026)
Table 4: Transcatheter Aortic Valve Replacement in the US Market Analysis (2018–2026)
Table 5: Transcatheter Aortic Valve Replacement Market Analysis in the US by procedure type (2018-2026)
Table 6: Transcatheter Aortic Valve Replacement Market Analysis in Germany (2018–2026)
Table 7: Transcatheter Aortic Valve Replacement Market Analysis in Germany by procedure type (2018-2026)
Table 8: Transcatheter Aortic Valve Replacement Market Analysis in France (2018–2026)
Table 9: Transcatheter Aortic Valve Replacement Market Analysis in France by procedure type (2018–2026)
Table 10: Transcatheter Aortic Valve Replacement Market Analysis in Spain (2018–2026)
Table 11: Transcatheter Aortic Valve Replacement Market Analysis in Spain by procedure type (2018–2026)
Table 12: Transcatheter Aortic Valve Replacement Market Analysis in Italy (2018–2026)
Table 13: Transcatheter Aortic Valve Replacement Market Analysis in Italy by procedure type (2018–2026)
Table 14: Transcatheter Aortic Valve Replacement Market Analysis in the United Kingdom (2018–2026)
Table 15: Transcatheter Aortic Valve Replacement Market Analysis in the United Kingdom by procedure type (2018–2026)
Table 16: Transcatheter Aortic Valve Replacement Market Analysis in Japan (2018–2026)
Table 17: Transcatheter Aortic Valve Replacement Market Analysis in Japan by procedure type (2018–2026)
List of Figures:
Figure 1: Product description of Transcatheter Aortic Valve Replacement
Figure 2: Transcatheter Aortic Valve Replacement Market Analysis in the 7MM (2018–2026)
Figure 3: Transcatheter Aortic Valve Replacement Market Analysis in the 7MM by procedure type (2018–2026)
Figure 4: Transcatheter Aortic Valve Replacement in the US Market Analysis (2018–2026)
Figure 5: Transcatheter Aortic Valve Replacement Market Analysis in the US by procedure type (2018-2026)
Figure 6: Transcatheter Aortic Valve Replacement Market Analysis in Germany (2018–2026)
Figure 7: Transcatheter Aortic Valve Replacement Market Analysis in Germany by procedure type (2018-2026)
Figure 8: Transcatheter Aortic Valve Replacement Market Analysis in France (2018–2026)
Figure 9: Transcatheter Aortic Valve Replacement Market Analysis in France by procedure type (2018–2026)
Figure 10: Transcatheter Aortic Valve Replacement Market Analysis in Spain (2018–2026)
Figure 11: Transcatheter Aortic Valve Replacement Market Analysis in Spain by procedure type (2018–2026)
Figure 12: Transcatheter Aortic Valve Replacement Market Analysis in Italy (2018–2026)
Figure 13: Transcatheter Aortic Valve Replacement Market Analysis in Italy by procedure type (2018–2026)
Figure 14: Transcatheter Aortic Valve Replacement Market Analysis in the United Kingdom (2018–2026)
Figure 15: Transcatheter Aortic Valve Replacement Market Analysis in the United Kingdom by procedure type (2018–2026)
Figure 16: Transcatheter Aortic Valve Replacement Market Analysis in Japan (2018–2026)
Figure 17: Transcatheter Aortic Valve Replacement Market Analysis in Japan by procedure type (2018–2026)
Figure 18: Market Drivers
Figure 19: Market Barriers
